logo

Metacrine, Inc. (MTCR)



Trade MTCR now with
  Date
  Headline
6/2/2021 8:19:42 AM Metacrine Completes Enrollment Of Phase 2a Trial Of MET409 With Empagliflozin In Type 2 Diabetes And NASH
4/5/2021 4:11:04 PM Metacrine Appoints Julia Owens To Its Board Of Directors
1/19/2021 6:49:29 AM Metacrine Secures FDA Fast Track Designation For MET642 As Treatment Of NASH
1/5/2021 6:43:08 AM Metacrine Begins Phase 2a Combination Trial Of MET409 With Empagliflozin